EYES
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.08 | $0 | -$6M |
| 2025 Q4 | -0.09 | $0 | -$7M |
| 2025 Q3 | -0.11 | $0 | -$5M |
| 2025 Q2 | -0.12 | $0 | -$8M |
| 2025 Q1 | -0.11 | $0 | -$5M |
| 2024 Q4 | 0.09 | -$260,000 | -$14M |
| 2022 Q2 | -0.23 | $0 | -$3M |
| 2022 Q1 | -0.17 | $0 | -$2M |